OHSU researchers test ginkgo biloba as possible agent to prevent or delay Alzheimer's disease

November 12, 2000

PORTLAND, Ore. -- For years scientists have been trying to stop Alzheimer's disease in those who already have been diagnosed. Now the first major study to investigate the possibility of preventing the disease in the oldest old is under way at Oregon Health Sciences University. Researchers in OHSU's Oregon Aging and Alzheimer's Disease Center, or OAADC, and the OHSU's Oregon Center for Complementary and Alternative Medicine in Neurological Disorders, or ORCCAMIND, are investigating the suggested benefits of the herbal remedy ginkgo biloba. Specifically, scientists would like to determine whether the herb could delay or prevent the early stages of Alzheimer's disease in older people. The research is funded by the National Center for Complementary and Alternative Medicine.

Currently ginkgo biloba is used around the world by alternative and complementary health providers who believe it improves cognitive function. In the United States alone, Americans spent $240 million on ginkgo biloba in 1997. While numerous clinical trials have investigated the possible cognitive benefits of the plant extract, only a small percentage of these studies were properly randomized, blinded, and used modern standards for diagnosis and assessment.

During OHSU's four-year study, researchers will focus on people 85 years and older. This group was chosen because they have the highest risk for developing mild cognitive impairment, a precursor to Alzheimer's disease. The scientists are looking for a total of 200 subjects who do not display signs of mental impairment. Each volunteer will receive regular checkups. Written and verbal tests will be used to determine whether there has been any significant cognitive degeneration during the span of the clinical trial. In addition, MRI testing will help detect changes in brain structure.

"People across the country and around the world believe that taking ginkgo biloba can aid in mental function and slow or prevent the onset of Alzheimer's," said Jeffrey Kaye, M.D., director of OAADC at OHSU and principal investigator of the study. "Right now we're trying to determine whether it works. We also want to know if this popular supplement could benefit the oldest portion of our population, the segment most likely to develop cognitive impairment."

"To many people, taking a natural substance such as ginkgo biloba to treat or prevent memory loss seems to be a safe thing to do. But the fact is, we need to recruit a group of older people who will participate in this clinical trial in order to understand the benefits and risks of ginkgo for persons who may develop mild cognitive impairment," said Neil Buckholtz, Ph.D., chief of the Dementias Branch at the National Institute on Aging.
-end-
This study begins as the country observes National Alzheimer's Awareness Month. Approximately 4 million Americans have Alzheimer's disease. One in 10 people 65 and older, and nearly half of those age 85 and older have Alzheimer's.

OHSU's clinical trial is one of the initial research projects of ORCCAMIND, a research center at OHSU focusing on alternative therapies for neurological disorders. The center was founded in 1999 through a $7.8 million dollar grant awarded by the National Center for Complementary and Alternative Medicine, a component of the National Institutes of Health.

Oregon Health & Science University

Related Aging Articles from Brightsurf:

Surprises in 'active' aging
Aging is a process that affects not only living beings.

Aging-US: 'From Causes of Aging to Death from COVID-19' by Mikhail V. Blagosklonny
Aging-US recently published ''From Causes of Aging to Death from COVID-19'' by Blagosklonny et al. which reported that COVID-19 is not deadly early in life, but mortality increases exponentially with age - which is the strongest predictor of mortality.

Understanding the effect of aging on the genome
EPFL scientists have measured the molecular footprint that aging leaves on various mouse and human tissues.

Muscle aging: Stronger for longer
With life expectancy increasing, age-related diseases are also on the rise, including sarcopenia, the loss of muscle mass due to aging.

Aging memories may not be 'worse, 'just 'different'
A study from the Department of Psychological & Brain Sciences in Arts & Sciences adds nuance to the idea that an aging memory is a poor one and finds a potential correlation between the way people process the boundaries of events and episodic memory.

A new biomarker for the aging brain
Researchers at the RIKEN Center for Biosystems Dynamics Research (BDR) in Japan have identified changes in the aging brain related to blood circulation.

Scientists invented an aging vaccine
A new way to prevent autoimmune diseases associated with aging like atherosclerosis, Alzheimer's disease, and Parkinson's disease was described in the article.

The first roadmap for ovarian aging
Infertility likely stems from age-related decline of the ovaries, but the molecular mechanisms that lead to this decline have been unclear.

Researchers discover new cause of cell aging
New research from the USC Viterbi School of Engineering could be key to our understanding of how the aging process works.

Deep Aging Clocks: The emergence of AI-based biomarkers of aging and longevity
The advent of deep biomarkers of aging, longevity and mortality presents a range of non-obvious applications.

Read More: Aging News and Aging Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.